Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026)
Ufp Technologies' (UFPT) quarterly Net Income towards Common Stockholders came in at $17.5 million in Q1 2026, up 1.81% YoY from $17.2 million in Q1 2025, and little changed on a QoQ basis from $17.6 million in Q4 2025.
Ufp Technologies (UFPT) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Ufp Technologies (UFPT) has 17 years of Net Income towards Common Stockholders data on file, last reported at $17.5 million in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 1.81% year-over-year to $17.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.6 million (up 8.12% YoY) and the FY2025 annual result came in at $68.3 million, up 15.82% from the prior year.
- Net Income towards Common Stockholders steadied at $17.5 million in Q1 2026, from $17.6 million in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $19.5 million in Q3 2022 to a low of $4.9 million in Q1 2022.
- A 5-year average of $13.6 million and a median of $13.6 million in 2024 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders jumped 415.7% — and 2023, when it tumbled 40.15%.
- Tracing UFPT's Net Income towards Common Stockholders over 5 years: stood at $8.5 million in 2022, then soared by 37.17% to $11.6 million in 2023, then jumped by 41.08% to $16.4 million in 2024, then increased by 7.27% to $17.6 million in 2025, then dropped by 0.4% to $17.5 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at $17.5 million (Q1 2026), $17.6 million (Q4 2025), and $16.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Ufp Technologies | 2.34 Bn | 2.33 Bn | 50.92 Mn | 20.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.85 Mn |
| Mar 31, 2026 | 17.50 Mn |
| Dec 31, 2025 | 17.57 Mn |
| Sep 30, 2025 | 16.38 Mn |
| Jun 30, 2025 | 17.18 Mn |
| Mar 31, 2025 | 17.18 Mn |
| Dec 31, 2024 | 16.38 Mn |
| Sep 30, 2024 | 16.36 Mn |
| Jun 30, 2024 | 13.55 Mn |
| Mar 31, 2024 | 12.69 Mn |
| Dec 31, 2023 | 11.61 Mn |
| Sep 30, 2023 | 11.69 Mn |
| Jun 30, 2023 | 11.88 Mn |
| Mar 31, 2023 | 9.74 Mn |
| Dec 31, 2022 | 8.46 Mn |
| Sep 30, 2022 | 19.54 Mn |
| Jun 30, 2022 | 8.93 Mn |
| Mar 31, 2022 | 4.86 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 3.79 Mn |